Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005829 | cytosol | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q3H3
Term | Name | Level | Count |
---|---|---|---|
GO:0001731 | formation of translation preinitiation complex | 7 | 2 |
GO:0001732 | formation of cytoplasmic translation initiation complex | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 2 |
GO:0043933 | protein-containing complex organization | 4 | 2 |
GO:0065003 | protein-containing complex assembly | 5 | 2 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003743 | translation initiation factor activity | 4 | 12 |
GO:0005092 | GDP-dissociation inhibitor activity | 3 | 2 |
GO:0005488 | binding | 1 | 12 |
GO:0005515 | protein binding | 2 | 2 |
GO:0008135 | translation factor activity, RNA binding | 3 | 12 |
GO:0030234 | enzyme regulator activity | 2 | 2 |
GO:0030695 | GTPase regulator activity | 4 | 2 |
GO:0031369 | translation initiation factor binding | 3 | 2 |
GO:0045182 | translation regulator activity | 1 | 12 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 2 |
GO:0071074 | eukaryotic initiation factor eIF2 binding | 4 | 2 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0098772 | molecular function regulator activity | 1 | 2 |
GO:0140677 | molecular function activator activity | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0005525 | GTP binding | 5 | 1 |
GO:0017076 | purine nucleotide binding | 4 | 1 |
GO:0019001 | guanyl nucleotide binding | 5 | 1 |
GO:0032553 | ribonucleotide binding | 3 | 1 |
GO:0032555 | purine ribonucleotide binding | 4 | 1 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 1 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 1 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043168 | anion binding | 3 | 1 |
GO:0097367 | carbohydrate derivative binding | 2 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.718 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.397 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.597 |
CLV_PCSK_KEX2_1 | 269 | 271 | PF00082 | 0.508 |
CLV_PCSK_KEX2_1 | 294 | 296 | PF00082 | 0.473 |
CLV_PCSK_PC1ET2_1 | 134 | 136 | PF00082 | 0.597 |
CLV_PCSK_PC1ET2_1 | 269 | 271 | PF00082 | 0.481 |
CLV_PCSK_PC1ET2_1 | 294 | 296 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 159 | 163 | PF00082 | 0.672 |
CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.612 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.603 |
CLV_PCSK_SKI1_1 | 266 | 270 | PF00082 | 0.525 |
CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.623 |
CLV_PCSK_SKI1_1 | 301 | 305 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.441 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.377 |
DEG_CRL4_CDT2_1 | 287 | 299 | PF00400 | 0.630 |
DEG_CRL4_CDT2_2 | 287 | 299 | PF00400 | 0.630 |
DOC_CDC14_PxL_1 | 271 | 279 | PF14671 | 0.609 |
DOC_MAPK_MEF2A_6 | 202 | 209 | PF00069 | 0.601 |
DOC_MAPK_MEF2A_6 | 319 | 326 | PF00069 | 0.445 |
DOC_PP1_RVXF_1 | 204 | 210 | PF00149 | 0.622 |
DOC_USP7_MATH_1 | 365 | 369 | PF00917 | 0.645 |
DOC_USP7_UBL2_3 | 187 | 191 | PF12436 | 0.808 |
DOC_USP7_UBL2_3 | 294 | 298 | PF12436 | 0.554 |
DOC_WW_Pin1_4 | 313 | 318 | PF00397 | 0.593 |
LIG_14-3-3_CanoR_1 | 135 | 139 | PF00244 | 0.577 |
LIG_14-3-3_CanoR_1 | 142 | 147 | PF00244 | 0.492 |
LIG_14-3-3_CanoR_1 | 229 | 237 | PF00244 | 0.579 |
LIG_14-3-3_CanoR_1 | 270 | 275 | PF00244 | 0.489 |
LIG_14-3-3_CanoR_1 | 69 | 78 | PF00244 | 0.455 |
LIG_APCC_ABBA_1 | 325 | 330 | PF00400 | 0.447 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.579 |
LIG_BIR_III_2 | 350 | 354 | PF00653 | 0.524 |
LIG_deltaCOP1_diTrp_1 | 340 | 348 | PF00928 | 0.662 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.573 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.793 |
LIG_FHA_2 | 25 | 31 | PF00498 | 0.377 |
LIG_FHA_2 | 271 | 277 | PF00498 | 0.515 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.385 |
LIG_LIR_Apic_2 | 232 | 237 | PF02991 | 0.603 |
LIG_LIR_Apic_2 | 238 | 243 | PF02991 | 0.571 |
LIG_LIR_Gen_1 | 318 | 328 | PF02991 | 0.544 |
LIG_LIR_Gen_1 | 75 | 85 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 91 | 102 | PF02991 | 0.249 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 318 | 323 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.362 |
LIG_PCNA_yPIPBox_3 | 88 | 97 | PF02747 | 0.364 |
LIG_Pex14_2 | 311 | 315 | PF04695 | 0.499 |
LIG_Pex14_2 | 96 | 100 | PF04695 | 0.362 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.377 |
LIG_SH2_CRK | 240 | 244 | PF00017 | 0.575 |
LIG_SH2_CRK | 94 | 98 | PF00017 | 0.362 |
LIG_SH2_NCK_1 | 234 | 238 | PF00017 | 0.622 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.447 |
LIG_SH3_2 | 182 | 187 | PF14604 | 0.801 |
LIG_SH3_2 | 7 | 12 | PF14604 | 0.483 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.805 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.504 |
LIG_UBA3_1 | 257 | 262 | PF00899 | 0.616 |
MOD_CDK_SPxK_1 | 313 | 319 | PF00069 | 0.592 |
MOD_CK1_1 | 189 | 195 | PF00069 | 0.800 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.678 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.487 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.776 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.377 |
MOD_CK2_1 | 270 | 276 | PF00069 | 0.518 |
MOD_Cter_Amidation | 117 | 120 | PF01082 | 0.447 |
MOD_Cter_Amidation | 132 | 135 | PF01082 | 0.447 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.445 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.815 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.547 |
MOD_GlcNHglycan | 30 | 34 | PF01048 | 0.396 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.462 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.746 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.573 |
MOD_GSK3_1 | 342 | 349 | PF00069 | 0.685 |
MOD_N-GLC_1 | 313 | 318 | PF02516 | 0.580 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.584 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.557 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.507 |
MOD_PIKK_1 | 229 | 235 | PF00454 | 0.553 |
MOD_PK_1 | 334 | 340 | PF00069 | 0.534 |
MOD_PKA_1 | 119 | 125 | PF00069 | 0.509 |
MOD_PKA_1 | 134 | 140 | PF00069 | 0.388 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.615 |
MOD_Plk_1 | 334 | 340 | PF00069 | 0.534 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.522 |
MOD_Plk_4 | 299 | 305 | PF00069 | 0.553 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.377 |
MOD_Plk_4 | 365 | 371 | PF00069 | 0.636 |
MOD_ProDKin_1 | 313 | 319 | PF00069 | 0.592 |
MOD_SUMO_rev_2 | 152 | 161 | PF00179 | 0.669 |
MOD_SUMO_rev_2 | 200 | 208 | PF00179 | 0.647 |
MOD_SUMO_rev_2 | 279 | 289 | PF00179 | 0.675 |
MOD_SUMO_rev_2 | 291 | 299 | PF00179 | 0.581 |
MOD_SUMO_rev_2 | 340 | 348 | PF00179 | 0.551 |
MOD_SUMO_rev_2 | 349 | 355 | PF00179 | 0.562 |
MOD_SUMO_rev_2 | 72 | 79 | PF00179 | 0.382 |
TRG_DiLeu_BaLyEn_6 | 226 | 231 | PF01217 | 0.588 |
TRG_DiLeu_BaLyEn_6 | 263 | 268 | PF01217 | 0.539 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.509 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.362 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.583 |
TRG_Pf-PMV_PEXEL_1 | 229 | 233 | PF00026 | 0.577 |
TRG_Pf-PMV_PEXEL_1 | 287 | 291 | PF00026 | 0.650 |
TRG_Pf-PMV_PEXEL_1 | 336 | 340 | PF00026 | 0.570 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I358 | Leptomonas seymouri | 77% | 100% |
A0A0S4KIP7 | Bodo saltans | 40% | 100% |
A0A1X0P9X7 | Trypanosomatidae | 46% | 97% |
A0A3Q8IE42 | Leishmania donovani | 99% | 100% |
A0A422NFJ1 | Trypanosoma rangeli | 36% | 100% |
A4HAE9 | Leishmania braziliensis | 95% | 100% |
A4I9K5 | Leishmania infantum | 99% | 100% |
D0A1W7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 99% |
E9B4K3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5DIM8 | Trypanosoma cruzi | 48% | 100% |